188 related articles for article (PubMed ID: 28550180)
1. A novel, de novo mutation in the
Xu Y; Gray A; Hardie DG; Uzun A; Shaw S; Padbury J; Phornphutkul C; Tseng YT
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H283-H292. PubMed ID: 28550180
[No Abstract] [Full Text] [Related]
2. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R
Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
4. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Din FV; Valanciute A; Houde VP; Zibrova D; Green KA; Sakamoto K; Alessi DR; Dunlop MG
Gastroenterology; 2012 Jun; 142(7):1504-15.e3. PubMed ID: 22406476
[TBL] [Abstract][Full Text] [Related]
5. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
Schramm C; Fine DM; Edwards MA; Reeb AN; Krenz M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H231-43. PubMed ID: 22058153
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.
Lee HJ; Mariappan MM; Feliers D; Cavaglieri RC; Sataranatarajan K; Abboud HE; Choudhury GG; Kasinath BS
J Biol Chem; 2012 Feb; 287(7):4451-61. PubMed ID: 22158625
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
[TBL] [Abstract][Full Text] [Related]
8. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
9. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
Kimball SR; Siegfried BA; Jefferson LS
J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
[TBL] [Abstract][Full Text] [Related]
10. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
Thomson DM; Fick CA; Gordon SE
J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
[TBL] [Abstract][Full Text] [Related]
11. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S
Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862
[TBL] [Abstract][Full Text] [Related]
12. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling.
Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592
[TBL] [Abstract][Full Text] [Related]
13. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
14. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR
J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410
[TBL] [Abstract][Full Text] [Related]
15. Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps.
Wang L; Wang X; Proud CG
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1056-68. PubMed ID: 10749698
[TBL] [Abstract][Full Text] [Related]
16. 4-Nonylphenol induces autophagy and attenuates mTOR-p70S6K/4EBP1 signaling by modulating AMPK activation in Sertoli cells.
Duan P; Hu C; Quan C; Yu T; Huang W; Chen W; Tang S; Shi Y; Martin FL; Yang K
Toxicol Lett; 2017 Feb; 267():21-31. PubMed ID: 28041982
[TBL] [Abstract][Full Text] [Related]
17. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
18. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
[TBL] [Abstract][Full Text] [Related]
19. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
20. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]